| 摘要 |
Pharmaceutical composition comprising a soluble form of CD160 for treatin g an inflammatory condition involving an undesired immune response, such as tissue graft or organ rejection, and autoimmune diseases; in vitro method fo r screening an individual for the presence of an inflammatory condition such as infectious and autoimmune diseases, tissue graft and organ rejection, or the presence of a tumor or activated endothelial cells, or for monitoring t herapy of an inflammatory condition such as an autoimmune disorder or a tiss ue or organ rejection, or a tumor during chemotherapy including treatment wi th an anti- angiogenic substance or antibody.
|
